NCT00588666View on ClinicalTrials.gov

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Myeloproliferative DisorderUrothelial CarcinomaCancer

Interventions

DRUG

Bevacizumab

DRUG

Carboplatin

DRUG

Gemcitabine

Trial Locations (6)

10065

Memorial Sloan-Kettering Cancer Center, New York

11570

Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre

11725

Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack

07920

Memorial Sloan-Kettering at Basking Ridge, Basking Ridge

Unknown

Memoral Sloan Kettering Cancer Center, Basking Ridge

Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00588666 - Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma | Biotech Hunter | Biotech Hunter